JAK1 and hydrops fetalis: Thus, the preventative and therapeutic effects of Ifidancitinib on AA mice may be in part due to the restoration of HF immune privilege by inhibiting IFN-γ and other forms of JAK1-dependent pro-inflammatory signaling (3, 4, 7).